Newron begins STARS study of sarizotan to treat Rett syndrome
Italian-based biopharmaceutical company Newron Pharmaceuticals has begun the Sarizotan Treatment of Apneas in Rett Syndrome (STARS) study of sarizotan to treat Rett syndrome.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news